MNPR
Monopar TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
MNPR Profile
Monopar Therapeutics Inc.
A biotech company developing cancer and rare disease treatments in the US
Biological Technology
12/05/2014
12/19/2019
NASDAQ Stock Exchange
22
12-31
Common stock
1000 Skokie Blvd.
Suite 350
Wilmette
IL 60091
--
Monopar Therapeutics Inc. was founded on December 5, 2014. The company is a clinical-stage biopharmaceutical company developing innovative treatments for Wilson's disease and novel radiopharmaceuticals in oncology.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
